{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:30:16Z","timestamp":1767652216958,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1864,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K24 CA184039-02","T-32 CA009515"],"award-info":[{"award-number":["K24 CA184039-02","T-32 CA009515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Listwin Family Foundation and Gregory Pilot Fund"},{"name":"Lymphoma Research Foundation Mantle Cell Lymphoma Initiative"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.exphem.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T06:00:32Z","timestamp":1484978432000},"page":"34-38.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications"],"prefix":"10.1016","volume":"49","author":[{"given":"Elahe A.","family":"Mostaghel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Mongovin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shani","family":"Frayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin L.","family":"Edlefsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver W.","family":"Press","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2017.01.001_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cncr.23608","article-title":"Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004","volume":"113","author":"Zhou","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2017.01.001_bib2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/0145-2126(85)90125-0","article-title":"Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines","volume":"9","author":"Danel","year":"1985","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2017.01.001_bib3","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V95.7.2289","article-title":"Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression","volume":"95","author":"Khetawat","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.01.001_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.yhbeh.2012.04.011","article-title":"Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity","volume":"62","author":"Kovats","year":"2012","journal-title":"Horm Behav"},{"key":"10.1016\/j.exphem.2017.01.001_bib5","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/en.2011-2120","article-title":"Immune cells have sex and so should journal articles","volume":"153","author":"Klein","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.exphem.2017.01.001_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2265.2004.02173.x","article-title":"Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis","volume":"62","author":"Sader","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.exphem.2017.01.001_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/path.1883","article-title":"Differential expression of oestrogen receptors in human secondary lymphoid tissues","volume":"208","author":"Shim","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2017.01.001_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00024382-200014040-00008","article-title":"Androgen and estrogen receptors in splenic T lymphocytes: effects of flutamide and trauma-hemorrhage","volume":"14","author":"Samy","year":"2000","journal-title":"Shock"},{"key":"10.1016\/j.exphem.2017.01.001_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/07357900802208590","article-title":"Androgen receptor CpG island methylation status in human leukemia cancer cells","volume":"27","author":"Liu","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1016\/j.exphem.2017.01.001_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1098-2264(200007)28:3<246::AID-GCC2>3.0.CO;2-0","article-title":"Involvement of the X chromosome in non-Hodgkin lymphoma","volume":"28","author":"McDonald","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2017.01.001_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0022-4731(84)90305-4","article-title":"Characterization of a specific androgen receptor in non-Hodgkin's lymphoma cells","volume":"21","author":"Danel","year":"1984","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.exphem.2017.01.001_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jcb.10313","article-title":"Oligonucleotide-based microarray for DNA methylation analysis: principles and applications","volume":"88","author":"Shi","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.exphem.2017.01.001_bib13","first-page":"4034","article-title":"The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas","volume":"9","author":"Yang","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2017.01.001_bib14","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2017.01.001_bib15","doi-asserted-by":"crossref","first-page":"e27970","DOI":"10.1371\/journal.pone.0027970","article-title":"Androgen receptor variants occur frequently in castration resistant prostate cancer metastases","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2017.01.001_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.exphem.2017.01.001_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(10)60172-9","article-title":"Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study","volume":"375","author":"Scher","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2017.01.001_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/pros.10199","article-title":"Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models","volume":"54","author":"Denmeade","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.exphem.2017.01.001_bib19","first-page":"4608","article-title":"Alterations of the cyclin D1\/p16-pRB pathway in mantle cell lymphoma","volume":"57","author":"Dreyling","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2017.01.001_bib20","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1158\/1078-0432.CCR-13-1863","article-title":"Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer","volume":"20","author":"Yu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2017.01.001_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-12-3630","article-title":"Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"73","author":"Li","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2017.01.001_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2011.68","article-title":"Effect of ligand-activated estrogen receptor beta on lymphoma growth in\u00a0vitro and in\u00a0vivo","volume":"25","author":"Yakimchuk","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.01.001_bib23","doi-asserted-by":"crossref","first-page":"31839","DOI":"10.1074\/jbc.M105185200","article-title":"Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.01.001_bib24","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1530\/ERC-14-0274","article-title":"Androgen signalling and steroid receptor crosstalk in endocrine cancers","volume":"21","author":"Claessens","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.exphem.2017.01.001_bib25","doi-asserted-by":"crossref","first-page":"T161","DOI":"10.1530\/ERC-14-0243","article-title":"Complexities of androgen receptor signalling in breast cancer","volume":"21","author":"McNamara","year":"2014","journal-title":"Endocr Relat Cancer"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17300115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X17300115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:24:23Z","timestamp":1654925063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X17300115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":25,"alternative-id":["S0301472X17300115"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2017.01.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}